Harmony Biosciences Holdings, I (HRMY) Financials

HRMY Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 847.0 million 331.6 million
2023-12-31 811.4 million 344.5 million
2023-09-30 777.8 million 296.4 million
2023-06-30 760.2 million 275.0 million

HRMY Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 31.1 million 10.4 million
2023-12-31 76.6 million 8.9 million
2023-09-30 63.1 million 8.0 million
2023-06-30 36.9 million 7.6 million

HRMY Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2024-03-31 38.3 million
2023-12-31 26.6 million
2023-09-30 38.5 million
2023-06-30 34.3 million

HRMY Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 372.4 million - -
2023-12-31 353.5 million - -
2023-09-30 370.7 million - -
2023-06-30 371.0 million 180.5 million -

HRMY Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 57.6 million
2023-12-31 58.9 million
2023-09-30 60.7 million
2023-06-30 60.7 million

HRMY Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 5000 22.2 million 25.7 million 27.2 million
2023-12-31 107000 30.3 million 27.9 million 26.9 million
2023-09-30 - 17.5 million 22.5 million 23.4 million
2023-06-30 205000 15.0 million 22.8 million 24.5 million

HRMY Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 154.6 million 27.5 million
2023-12-31 168.4 million 43.2 million
2023-09-30 160.3 million 32.3 million
2023-06-30 134.2 million 25.0 million

HRMY

Price: $31.57

52 week price:
18.61
39.27

Earnings Per Share: 2.13 USD

P/E Ratio: 13.71

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 87588

Market Capitalization: 1.7 billion

Links: